<?xml version="1.0" encoding="UTF-8"?>
<billStatus>
  <bill>
    <committees>
      <billCommittees>
        <item>
          <activities>
            <item>
              <name>Referred to</name>
              <date>2015-01-13T15:03:50Z</date>
            </item>
          </activities>
          <name>Energy and Commerce Committee</name>
          <chamber>House</chamber>
          <systemCode>hsif00</systemCode>
          <subcommittees>
            <item>
              <activities>
                <item>
                  <name>Referred to</name>
                  <date>2015-01-16T17:53:47Z</date>
                </item>
              </activities>
              <name>Health Subcommittee</name>
              <systemCode>hsif14</systemCode>
            </item>
          </subcommittees>
          <type>Standing</type>
        </item>
      </billCommittees>
    </committees>
    <relatedBills />
    <summaries>
      <billSummaries>
        <item>
          <updateDate>2015-01-13T05:00:00Z</updateDate>
          <versionCode>00</versionCode>
          <actionDesc>Introduced in House</actionDesc>
          <name>Introduced in House</name>
          <text><![CDATA[<p><b>Medical Testing Availability Act of 2015</b></p> <p>This bill amends the Federal Food, Drug, and Cosmetic Act to prohibit a product labeled for research use only from being deemed adulterated or misbranded on the basis that its manufacturer or distributor: (1) sells the product to an end user who uses the product for a purpose other than research, or (2) engages in business communications with an end user regarding the product.</p>]]></text>
          <actionDate>2015-01-13</actionDate>
          <lastSummaryUpdateDate>2015-04-02T15:33:19Z</lastSummaryUpdateDate>
        </item>
      </billSummaries>
    </summaries>
    <updateDate>2018-11-21T21:22:57Z</updateDate>
    <laws />
    <subjects>
      <billSubjects>
        <policyArea>
          <name>Health</name>
        </policyArea>
        <legislativeSubjects>
          <item>
            <name>Consumer affairs</name>
          </item>
          <item>
            <name>Drug safety, medical device, and laboratory regulation</name>
          </item>
          <item>
            <name>Health technology, devices, supplies</name>
          </item>
          <item>
            <name>Medical research</name>
          </item>
          <item>
            <name>Product safety and quality</name>
          </item>
        </legislativeSubjects>
      </billSubjects>
    </subjects>
    <latestAction>
      <links />
      <actionDate>2015-01-16</actionDate>
      <text>Referred to the Subcommittee on Health.</text>
    </latestAction>
    <billType>HR</billType>
    <originChamber>House</originChamber>
    <committeeReports />
    <policyArea>
      <name>Health</name>
    </policyArea>
    <titles>
      <item>
        <chamberName />
        <chamberCode />
        <titleType>Short Titles as Introduced</titleType>
        <parentTitleType />
        <title>Medical Testing Availability Act of 2015</title>
      </item>
      <item>
        <chamberName />
        <chamberCode />
        <titleType>Official Title as Introduced</titleType>
        <parentTitleType />
        <title>To amend chapter V of the Federal Food, Drug, and Cosmetic Act to permit the sale of, and access to, "research use only" products.</title>
      </item>
      <item>
        <chamberName />
        <chamberCode />
        <titleType>Display Title</titleType>
        <parentTitleType />
        <title>Medical Testing Availability Act of 2015</title>
      </item>
    </titles>
    <cosponsors>
      <item>
        <state>CA</state>
        <district>14</district>
        <party>D</party>
        <sponsorshipWithdrawnDate />
        <identifiers>
          <gpoId>7817</gpoId>
          <lisID>1890</lisID>
          <bioguideId>S001175</bioguideId>
        </identifiers>
        <middleName />
        <fullName>Rep. Speier, Jackie [D-CA-14]</fullName>
        <bioguideId>S001175</bioguideId>
        <sponsorshipDate>2015-01-13</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
        <lastName>Speier</lastName>
        <firstName>Jackie</firstName>
      </item>
    </cosponsors>
    <actions>
      <actionTypeCounts>
        <billReferrals>1</billReferrals>
        <placeholderTextForH>1</placeholderTextForH>
        <introducedInTheHouse>1</introducedInTheHouse>
        <introducedInHouse>1</introducedInHouse>
      </actionTypeCounts>
      <actionByCounts>
        <houseOfRepresentatives>4</houseOfRepresentatives>
      </actionByCounts>
      <item>
        <actionDate>2015-01-16</actionDate>
        <committee>
          <systemCode>hsif14</systemCode>
          <name>Health Subcommittee</name>
        </committee>
        <links />
        <sourceSystem>
          <code>1</code>
          <name>House committee actions</name>
        </sourceSystem>
        <text>Referred to the Subcommittee on Health.</text>
        <type>Committee</type>
      </item>
      <item>
        <actionDate>2015-01-13</actionDate>
        <committee>
          <systemCode>hsif00</systemCode>
          <name>Energy and Commerce Committee</name>
        </committee>
        <actionCode>H11100</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <links />
        <text>Referred to the House Committee on Energy and Commerce.</text>
        <type>IntroReferral</type>
      </item>
      <item>
        <actionDate>2015-01-13</actionDate>
        <committee />
        <actionCode>Intro-H</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
        <links />
        <text>Introduced in House</text>
        <type>IntroReferral</type>
      </item>
      <item>
        <actionDate>2015-01-13</actionDate>
        <committee />
        <actionCode>1000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
        <links />
        <text>Introduced in House</text>
        <type>IntroReferral</type>
      </item>
    </actions>
    <notes />
    <introducedDate>2015-01-13</introducedDate>
    <recordedVotes />
    <billNumber>298</billNumber>
    <sponsors>
      <item>
        <byRequestType />
        <middleName>C.</middleName>
        <state>TX</state>
        <firstName>Michael</firstName>
        <fullName>Rep. Burgess, Michael C. [R-TX-26]</fullName>
        <bioguideId>B001248</bioguideId>
        <party>R</party>
        <lastName>Burgess</lastName>
        <identifiers>
          <gpoId>8182</gpoId>
          <lisID>1751</lisID>
          <bioguideId>B001248</bioguideId>
        </identifiers>
        <district>26</district>
      </item>
    </sponsors>
    <congress>114</congress>
    <createDate>2015-01-14T04:46:23Z</createDate>
    <calendarNumbers />
    <constitutionalAuthorityStatementText><![CDATA[<pre>[Congressional Record Volume 161, Number 6 (Tuesday, January 13, 2015)]From the Congressional Record Online through the Government Publishing Office [<a href='http://www.gpo.gov'>www.gpo.gov</a>]By Mr. BURGESS:H.R. 298.Congress has the power to enact this legislation pursuantto the following:The attached bill is constitutional under Article I,Section VIII. ``The Congress shall have Power To regulateCommerce with foreign Nations, and among the severalStates.''[Page H359]</pre>]]></constitutionalAuthorityStatementText>
    <cboCostEstimates />
    <amendments />
    <version>1.0.0</version>
    <title>Medical Testing Availability Act of 2015</title>
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>

